Obamacare’s first
catastrophe: Drug shortages
Prescription drug shortages
have become evident throughout the country, in every major pharmaceutical
category, over the last two years. Concurrent with the initiation of Obamacare
Hospitals and clinics have reported major scarcities in an array of drugs,
which is presently reaching a critical point. People who are victims of cancer
have found that needed chemotherapies have dwindled to a point where they are
unavailable in many locales. One report noted that drugs for Hodgkin’s Lymphoma
are becoming so scarce physicians are forced to withhold therapies from some. Emergency
medical teams, in many jurisdictions, have resorted to using outdated drugs for
lack of availability of a fresh supply. Intensive care units are are unable to obtain
there full complement of cardiology therapies from manufacturers. Pediatric
vaccines are not finding their way into physicians’ offices to fulfill demand.
Deficits in anesthetic supplies have delayed many surgeries. The dearth of
injectable drugs is the most profound of the scarcities. Some pharmaceutical
representatives state that manufacturing capacity has been reduced do to
permanent facility closings and or to address quality issues in these
production centers. Others note raw materials are not in abundant supply. In
January 2013 many have gone to their local pharmacies to find price increases
in their usual medications, some as high as 400 percent. Those in the know
believe the heavy hand of government has triggered these shortages. FDA officials
have been oppressive in their enforcement efforts against pharmaceutical
manufacturers causing plants to bring production to a virtual standstill or
even close. New financial burdens created by Obamacare and the slow thinkers in
Washington have made the end-product, medications, much less profitable to
produce. With less profit there will be reduced availability of a product or
service, basic capitalism 101, something the creators of Obamacare forgot.
Government officials claim they are trying to reduce the burden on
manufacturers with easing up on some regulations, better communications with
suppliers, quickening the pace of certain drug approvals and attempting to
provide a cooperative effort between regulators and the private sector. In the
event you live in the Obama fantasy world and accept the government’s
explanation for the shortages so be it. Democrats have been pointing their
fingers in a number of directions to blame anyone but themselves for these shortages.
With the full implementation of Obamacare eleven months in the future, the
problems embedded in this article will become more intense as the months move
forward. Death is too high a price to pay for the President’s experiment in
socialized medicine. Unfortunately, it is very likely that many will perish
from the lack therapies available, the very promise made by the President would
not happen under his ill-conceived health program. Mark Davis, MD, platomd@gmail.com www.healthnetsreviewservices.com
Author of the forthcoming
book, Obamacare: Dead on Arrival, A Presciption for Disaster.